My NCBI | Sign In
RSS Settings
  • Search: Terai K

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 95

    1.

    PKC-alpha inhibitor MT477 slows tumor growth with minimal toxicity in in vivo model of non-Ras-mutated cancer via induction of apoptosis.

    Jasinski P, Zwolak P, Terai K, Borja-Cacho D, Dudek AZ.

    Invest New Drugs. 2009 Oct 1. [Epub ahead of print]PMID: 19795097 [PubMed - as supplied by publisher]Related articles

    2.

    Cisplatin enhances the anticancer effect of beta-lapachone by upregulating NQO1.

    Terai K, Dong GZ, Oh ET, Park MT, Gu Y, Song CW, Park HJ.

    Anticancer Drugs. 2009 Nov;20(10):901-9.PMID: 19738461 [PubMed - in process]Related articles

    3.

    Novel insulin-like growth factor-methotrexate covalent conjugate inhibits tumor growth in vivo at lower dosage than methotrexate alone.

    McTavish H, Griffin RJ, Terai K, Dudek AZ.

    Transl Res. 2009 Jun;153(6):275-82. Epub 2009 Mar 14.PMID: 19446281 [PubMed - indexed for MEDLINE]Related articles

    4.

    Vascular calcification and secondary hyperparathyroidism of severe chronic kidney disease and its relation to serum phosphate and calcium levels.

    Terai K, Nara H, Takakura K, Mizukami K, Sanagi M, Fukushima S, Fujimori A, Itoh H, Okada M.

    Br J Pharmacol. 2009 Apr;156(8):1267-78. Epub 2009 Mar 19.PMID: 19302594 [PubMed - in process]Related articles

    5.

    MHC-matched corneal allograft rejection in an IFN-gamma/IL-17-independent manner in C57BL/6 mice.

    Yamada J, Hamuro J, Fukushima A, Ohteki T, Terai K, Iwakura Y, Yagita H, Kinoshita S.

    Invest Ophthalmol Vis Sci. 2009 May;50(5):2139-46. Epub 2009 Jan 10.PMID: 19136699 [PubMed - indexed for MEDLINE]Related articles

    6.

    [Expression of toll-like receptor 4 in colorectal cancer]

    Nihon-yanagi Y, Park Y, Ooshiro M, Terai K, Matsumoto T, Murano T, Okazumi S.

    Gan To Kagaku Ryoho. 2008 Nov;35(12):2247-9. Japanese. PMID: 19106585 [PubMed - indexed for MEDLINE]Related articles

    7.

    Novel Ras pathway inhibitor induces apoptosis and growth inhibition of K-ras-mutated cancer cells in vitro and in vivo.

    Jasinski P, Zwolak P, Terai K, Dudek AZ.

    Transl Res. 2008 Nov;152(5):203-12. Epub 2008 Oct 11.PMID: 19010291 [PubMed - indexed for MEDLINE]Related articles

    8.

    PCNA-dependent regulation of p21 ubiquitylation and degradation via the CRL4Cdt2 ubiquitin ligase complex.

    Abbas T, Sivaprasad U, Terai K, Amador V, Pagano M, Dutta A.

    Genes Dev. 2008 Sep 15;22(18):2496-506.PMID: 18794347 [PubMed - indexed for MEDLINE]Related articlesFree article

    9.

    Addition of receptor tyrosine kinase inhibitor to radiation increases tumour control in an orthotopic murine model of breast cancer metastasis in bone.

    Zwolak P, Jasinski P, Terai K, Gallus NJ, Ericson ME, Clohisy DR, Dudek AZ.

    Eur J Cancer. 2008 Nov;44(16):2506-17. Epub 2008 Aug 22.PMID: 18723339 [PubMed - indexed for MEDLINE]Related articles

    10.

    Preparation of leukotriene B(4) inhibitory active 2- and 3-(2-aminothiazol-4-yl)benzo[b]furan derivatives and their growth inhibitory activity on human pancreatic cancer cells.

    Kuramoto M, Sakata Y, Terai K, Kawasaki I, Kunitomo J, Ohishi T, Yokomizo T, Takeda S, Tanaka S, Ohishi Y.

    Org Biomol Chem. 2008 Aug 7;6(15):2772-81. Epub 2008 May 29.PMID: 18633535 [PubMed - indexed for MEDLINE]Related articles

    11.

    Enzastaurin renders MCF-7 breast cancer cells sensitive to radiation through reversal of radiation-induced activation of protein kinase C.

    Jasinski P, Terai K, Zwolak P, Dudek AZ.

    Eur J Cancer. 2008 Jun;44(9):1315-22. Epub 2008 Apr 28.PMID: 18448327 [PubMed - indexed for MEDLINE]Related articles

    12.

    The evolutionarily conserved G protein-coupled receptor SREB2/GPR85 influences brain size, behavior, and vulnerability to schizophrenia.

    Matsumoto M, Straub RE, Marenco S, Nicodemus KK, Matsumoto S, Fujikawa A, Miyoshi S, Shobo M, Takahashi S, Yarimizu J, Yuri M, Hiramoto M, Morita S, Yokota H, Sasayama T, Terai K, Yoshino M, Miyake A, Callicott JH, Egan MF, Meyer-Lindenberg A, Kempf L, Honea R, Vakkalanka RK, Takasaki J, Kamohara M, Soga T, Hiyama H, Ishii H, Matsuo A, Nishimura S, Matsuoka N, Kobori M, Matsushime H, Katoh M, Furuichi K, Weinberger DR.

    Proc Natl Acad Sci U S A. 2008 Apr 22;105(16):6133-8. Epub 2008 Apr 14.PMID: 18413613 [PubMed - indexed for MEDLINE]Related articlesFree article

    13.

    Comparison of chronic renal failure rats and modification of the preparation protocol as a hyperphosphataemia model.

    Terai K, Mizukami K, Okada M.

    Nephrology (Carlton). 2008 Apr;13(2):139-46.PMID: 18275502 [PubMed - indexed for MEDLINE]Related articles

    14.

    Major histocompatibility complex semi-matching improves murine corneal allograft survival under oxidative macrophage dominancy.

    Yamada J, Hamuro J, Terai K, Kinoshita S.

    Transplantation. 2007 Oct 15;84(7):899-907.PMID: 17984844 [PubMed - indexed for MEDLINE]Related articles

    15.

    A novel quinoline, MT477: suppresses cell signaling through Ras molecular pathway, inhibits PKC activity, and demonstrates in vivo anti-tumor activity against human carcinoma cell lines.

    Jasinski P, Welsh B, Galvez J, Land D, Zwolak P, Ghandi L, Terai K, Dudek AZ.

    Invest New Drugs. 2008 Jun;26(3):223-32. Epub 2007 Oct 24.PMID: 17957339 [PubMed - indexed for MEDLINE]Related articles

    16.

    Recovery of spectral reflectances of objects being imaged by multispectral cameras.

    Shimano N, Terai K, Hironaga M.

    J Opt Soc Am A Opt Image Sci Vis. 2007 Oct;24(10):3211-9.PMID: 17912312 [PubMed]Related articles

    17.

    Protein kinase C-beta inhibitor enzastaurin (LY317615.HCI) enhances radiation control of murine breast cancer in an orthotopic model of bone metastasis.

    Dudek AZ, Zwolak P, Jasinski P, Terai K, Gallus NJ, Ericson ME, Farassati F.

    Invest New Drugs. 2008 Feb;26(1):13-24. Epub 2007 Sep 6.PMID: 17805485 [PubMed - indexed for MEDLINE]Related articles

    18.

    Upregulation of NAD(P)H:quinone oxidoreductase by radiation potentiates the effect of bioreductive beta-lapachone on cancer cells.

    Choi EK, Terai K, Ji IM, Kook YH, Park KH, Oh ET, Griffin RJ, Lim BU, Kim JS, Lee DS, Boothman DA, Loren M, Song CW, Park HJ.

    Neoplasia. 2007 Aug;9(8):634-42.PMID: 17786182 [PubMed - indexed for MEDLINE]Related articlesFree article

    19.

    Antiangiogenesis therapy using a novel angiogenesis inhibitor, anginex, following radiation causes tumor growth delay.

    Amano M, Suzuki M, Andoh S, Monzen H, Terai K, Williams B, Song CW, Mayo KH, Hasegawa T, Dings RP, Griffin RJ.

    Int J Clin Oncol. 2007 Feb;12(1):42-7. Epub 2007 Feb 25.PMID: 17380440 [PubMed - indexed for MEDLINE]Related articles

    20.

    Human MDR1 and MRP1 recognize berberine as their transport substrate.

    Shitan N, Tanaka M, Terai K, Ueda K, Yazaki K.

    Biosci Biotechnol Biochem. 2007 Jan;71(1):242-5. Epub 2007 Jan 7.PMID: 17213652 [PubMed - indexed for MEDLINE]Related articlesFree article

    Supplemental Content

    Filter your results:

    7 free full-text articles in PubMed Central

    Find related data

    Search details

    » See more...

    Recent activity